Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
Thursday, May 31, 2012 - 6:26pm
tags:
MannKind, IRE1α inhibitor, MKC-3946, Multiple Myeloma
Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says
Bloomberg
Thursday, May 31, 2012 - 6:17pm
tags:
R&D, Sanofi
BioMarin to Raise Funds
Yahoo/Zacks
Thursday, May 31, 2012 - 6:15pm
tags:
Biomarin, stock offering
Human Genome Sciences Takeover Defense Survives Court Test
Bloomberg
Thursday, May 31, 2012 - 6:13pm
tags:
Human Genome Sciences, GSK, M&A, hostile bid
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thursday, May 31, 2012 - 6:11pm
tags:
Sanofi, liver cancer, GSK, AstraZeneca, Bristol-Myers Squibb
No Good News for Waiting Chelsea Investors
Motley Fool
Thursday, May 31, 2012 - 6:09pm
tags:
Chelsea Therapeutics, Northera, CH-4051, rheumatoid arthritis
The Drug Works, but Is It Worth Proceeding?
Motley Fool
Thursday, May 31, 2012 - 6:08pm
tags:
Alnylam, ALN-RSV01
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Thursday, May 31, 2012 - 10:17am
tags:
Medivation, prostate cancer, MDV3100, Astellas
Teva Begins Trading on the New York Stock Exchange
Yahoo
Thursday, May 31, 2012 - 10:14am
tags:
Teva Pharmaceuticals, NYSE
Icahn nominates new directors to Forest Labs board
Yahoo/AP
Thursday, May 31, 2012 - 10:11am
tags:
Carl Icahn, Forest Labs
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thursday, May 31, 2012 - 9:38am
tags:
AstraZeneca, JNJ, Bristol-Myers Squibb, Eli Lilly, Pfizer, Sanofi, GSK
Ampio Pharmaceuticals Is On The Move
Seeking Alpha
Thursday, May 31, 2012 - 9:31am
tags:
Ampio Pharmaceuticals, Zertane
The Tale of 2 Patents
Motley Fool
Thursday, May 31, 2012 - 9:24am
tags:
patents, Amarin, AMR-101, GSK, Teva Pharmaceuticals, Par Pharmaceutical, Pronova BioPharma ASA
Merck, Pfizer Back Lawmakers Who Oppose Company Products
Bloomberg
Thursday, May 31, 2012 - 9:16am
tags:
Merck, Pfizer, contraceptives, healthcare reform
Buy This Pharma Giant Now For A 30% Return In 2013
Seeking Alpha
Wednesday, May 30, 2012 - 3:04pm
tags:
JNJ, Bayer, Pfizer, Ranbaxy, Bristol-Myers Squibb
Abbott's Pipeline Is Crucial In Advance Of 2016 Patent Cliff
Forbes
Wednesday, May 30, 2012 - 3:03pm
tags:
Abbott Laboratories, patents, patent cliff, Kaletra, Humira
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wednesday, May 30, 2012 - 3:01pm
tags:
Amylin, M&A, AstraZeneca, Bristol-Myers Squibb, Pfizer
Pfizer Cleared Of Liability In Prempro Breast Cancer Case
Bloomberg
Wednesday, May 30, 2012 - 2:58pm
tags:
Wyeth, Prempro, breast cancer, Pfizer, HRT
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wednesday, May 30, 2012 - 11:30am
tags:
generics, Effient, Plavix, Brilinta, Eli Lilly, bloodthinners, AstraZeneca, Sanofi, Bristol-Myers Squibb
Osiris shares up as FDA clears reimbursement pathway for wound treatment
Reuters
Wednesday, May 30, 2012 - 11:27am
tags:
FDA, reimbursement, wound care

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.